Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
Clinical trial NCT05273944 · UNKNOWN
Trial details
- NCT number
- NCT05273944
- Sponsor
- Shenzhen Kangzhe Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2022-03-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.